- Home
- MFM vs PROF Comparison
MFM vs PROF Comparison
Compare MFM & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFM
- PROF
- Stock Information
- Founded
- MFM 1986
- PROF N/A
- Country
- MFM United States
- PROF Canada
- Employees
- MFM N/A
- PROF N/A
- Industry
- MFM Finance Companies
- PROF Medical/Dental Instruments
- Sector
- MFM Finance
- PROF Health Care
- Exchange
- MFM Nasdaq
- PROF Nasdaq
- Market Cap
- MFM 231.9M
- PROF 186.3M
- IPO Year
- MFM N/A
- PROF N/A
- Fundamental
- Price
- MFM $5.46
- PROF $7.08
- Analyst Decision
- MFM
- PROF Strong Buy
- Analyst Count
- MFM 0
- PROF 2
- Target Price
- MFM N/A
- PROF $11.40
- AVG Volume (30 Days)
- MFM 108.1K
- PROF 98.7K
- Earning Date
- MFM 01-01-0001
- PROF 11-07-2024
- Dividend Yield
- MFM 4.08%
- PROF N/A
- EPS Growth
- MFM N/A
- PROF N/A
- EPS
- MFM 0.03
- PROF N/A
- Revenue
- MFM N/A
- PROF $8,984,000.00
- Revenue This Year
- MFM N/A
- PROF $56.61
- Revenue Next Year
- MFM N/A
- PROF $160.87
- P/E Ratio
- MFM $176.67
- PROF N/A
- Revenue Growth
- MFM N/A
- PROF 39.35
- 52 Week Low
- MFM $4.37
- PROF $6.88
- 52 Week High
- MFM $5.48
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- MFM 29.61
- PROF 39.29
- Support Level
- MFM $5.60
- PROF $6.88
- Resistance Level
- MFM $5.69
- PROF $8.75
- Average True Range (ATR)
- MFM 0.06
- PROF 0.39
- MACD
- MFM -0.02
- PROF -0.08
- Stochastic Oscillator
- MFM 6.24
- PROF 19.26
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.